Nandini Nayar

Global Digital Health and Innovation Lead, Sanofi

Mark Bard, with DHC Group, and Nandini Nayar, Global Digital Health and Innovation Lead, Sanofi, discussed the evolution of patient-centricity, patient experience, and overall digital health trends in the pharmaceutical industry. The conversation also discussed challenges in the clinical trial processes and the potential for innovation in patient access for specialty medications. They also explored the potential for pharmaceutical companies to fund the creation of models and care pathways to improve patient diagnosis and control, and the importance of integrating these tools into physicians’ workflows.